Article Details
Retrieved on: 2025-04-14 18:11:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
VERVE-102, a gene-editing therapy that permanently shuts off the PCSK9 gene in the liver and limits LDL-cholesterol production, is showing promise in ...
Article found on: www.tctmd.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here